nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxymesterone—Betamethasone—hematologic cancer	0.0902	0.258	CrCtD
Fluoxymesterone—Dexamethasone—hematologic cancer	0.0902	0.258	CrCtD
Fluoxymesterone—Triamcinolone—hematologic cancer	0.0881	0.252	CrCtD
Fluoxymesterone—AR—hematologic cancer	0.0853	0.409	CbGaD
Fluoxymesterone—Prednisolone—hematologic cancer	0.0816	0.233	CrCtD
Fluoxymesterone—ESR1—hematologic cancer	0.0657	0.315	CbGaD
Fluoxymesterone—NR3C1—hematologic cancer	0.0579	0.277	CbGaD
Fluoxymesterone—NR3C1—Triamcinolone—hematologic cancer	0.0198	0.25	CbGbCtD
Fluoxymesterone—NR3C1—Betamethasone—hematologic cancer	0.017	0.214	CbGbCtD
Fluoxymesterone—NR3C1—Prednisolone—hematologic cancer	0.0168	0.211	CbGbCtD
Fluoxymesterone—NR3C1—Prednisone—hematologic cancer	0.0158	0.2	CbGbCtD
Fluoxymesterone—NR3C1—Dexamethasone—hematologic cancer	0.00989	0.125	CbGbCtD
Fluoxymesterone—Potassium Canrenoate—Prednisone—hematologic cancer	0.0048	0.0208	CrCrCtD
Fluoxymesterone—Potassium Canrenoate—Prednisolone—hematologic cancer	0.00468	0.0203	CrCrCtD
Fluoxymesterone—ESR1—ovarian follicle—hematologic cancer	0.00455	0.292	CbGeAlD
Fluoxymesterone—Danazol—Prednisone—hematologic cancer	0.00405	0.0176	CrCrCtD
Fluoxymesterone—Testolactone—Betamethasone—hematologic cancer	0.00357	0.0155	CrCrCtD
Fluoxymesterone—Testolactone—Dexamethasone—hematologic cancer	0.00357	0.0155	CrCrCtD
Fluoxymesterone—Hydrocortamate—Prednisone—hematologic cancer	0.00352	0.0153	CrCrCtD
Fluoxymesterone—Testolactone—Triamcinolone—hematologic cancer	0.00349	0.0151	CrCrCtD
Fluoxymesterone—Hydrocortamate—Prednisolone—hematologic cancer	0.00344	0.0149	CrCrCtD
Fluoxymesterone—Cortisone acetate—Prednisone—hematologic cancer	0.00341	0.0148	CrCrCtD
Fluoxymesterone—Cortisone acetate—Prednisolone—hematologic cancer	0.00333	0.0145	CrCrCtD
Fluoxymesterone—Testolactone—Prednisone—hematologic cancer	0.00331	0.0144	CrCrCtD
Fluoxymesterone—Amcinonide—Dexamethasone—hematologic cancer	0.00328	0.0142	CrCrCtD
Fluoxymesterone—Amcinonide—Betamethasone—hematologic cancer	0.00328	0.0142	CrCrCtD
Fluoxymesterone—Testolactone—Prednisolone—hematologic cancer	0.00323	0.014	CrCrCtD
Fluoxymesterone—Amcinonide—Triamcinolone—hematologic cancer	0.00321	0.0139	CrCrCtD
Fluoxymesterone—Fludrocortisone—Betamethasone—hematologic cancer	0.0032	0.0139	CrCrCtD
Fluoxymesterone—Fludrocortisone—Dexamethasone—hematologic cancer	0.0032	0.0139	CrCrCtD
Fluoxymesterone—Clobetasol propionate—Betamethasone—hematologic cancer	0.0032	0.0139	CrCrCtD
Fluoxymesterone—Clobetasol propionate—Dexamethasone—hematologic cancer	0.0032	0.0139	CrCrCtD
Fluoxymesterone—Fludrocortisone—Triamcinolone—hematologic cancer	0.00313	0.0136	CrCrCtD
Fluoxymesterone—Clobetasol propionate—Triamcinolone—hematologic cancer	0.00313	0.0136	CrCrCtD
Fluoxymesterone—Amcinonide—Prednisone—hematologic cancer	0.00304	0.0132	CrCrCtD
Fluoxymesterone—Desoximetasone—Betamethasone—hematologic cancer	0.00304	0.0132	CrCrCtD
Fluoxymesterone—Desoximetasone—Dexamethasone—hematologic cancer	0.00304	0.0132	CrCrCtD
Fluoxymesterone—Desoximetasone—Triamcinolone—hematologic cancer	0.00297	0.0129	CrCrCtD
Fluoxymesterone—Amcinonide—Prednisolone—hematologic cancer	0.00297	0.0129	CrCrCtD
Fluoxymesterone—Fluorometholone—Dexamethasone—hematologic cancer	0.00297	0.0129	CrCrCtD
Fluoxymesterone—Fluorometholone—Betamethasone—hematologic cancer	0.00297	0.0129	CrCrCtD
Fluoxymesterone—Triamcinolone—Dexamethasone—hematologic cancer	0.00297	0.0129	CrCrCtD
Fluoxymesterone—Mometasone—Betamethasone—hematologic cancer	0.00297	0.0129	CrCrCtD
Fluoxymesterone—Mometasone—Dexamethasone—hematologic cancer	0.00297	0.0129	CrCrCtD
Fluoxymesterone—Fluprednidene Acetate—Dexamethasone—hematologic cancer	0.00297	0.0129	CrCrCtD
Fluoxymesterone—Fluprednidene Acetate—Betamethasone—hematologic cancer	0.00297	0.0129	CrCrCtD
Fluoxymesterone—Loteprednol—Dexamethasone—hematologic cancer	0.00297	0.0129	CrCrCtD
Fluoxymesterone—Loteprednol—Betamethasone—hematologic cancer	0.00297	0.0129	CrCrCtD
Fluoxymesterone—Triamcinolone—Betamethasone—hematologic cancer	0.00297	0.0129	CrCrCtD
Fluoxymesterone—Fludrocortisone—Prednisone—hematologic cancer	0.00297	0.0129	CrCrCtD
Fluoxymesterone—Clobetasol propionate—Prednisone—hematologic cancer	0.00297	0.0129	CrCrCtD
Fluoxymesterone—Betamethasone—Dexamethasone—hematologic cancer	0.0029	0.0126	CrCrCtD
Fluoxymesterone—Dexamethasone—Betamethasone—hematologic cancer	0.0029	0.0126	CrCrCtD
Fluoxymesterone—Fluprednidene Acetate—Triamcinolone—hematologic cancer	0.0029	0.0126	CrCrCtD
Fluoxymesterone—Loteprednol—Triamcinolone—hematologic cancer	0.0029	0.0126	CrCrCtD
Fluoxymesterone—Fluorometholone—Triamcinolone—hematologic cancer	0.0029	0.0126	CrCrCtD
Fluoxymesterone—Mometasone—Triamcinolone—hematologic cancer	0.0029	0.0126	CrCrCtD
Fluoxymesterone—Progesterone—Prednisolone—hematologic cancer	0.0029	0.0126	CrCrCtD
Fluoxymesterone—Fludrocortisone—Prednisolone—hematologic cancer	0.0029	0.0126	CrCrCtD
Fluoxymesterone—Clobetasol propionate—Prednisolone—hematologic cancer	0.0029	0.0126	CrCrCtD
Fluoxymesterone—Methyltestosterone—Prednisone—hematologic cancer	0.00289	0.0125	CrCrCtD
Fluoxymesterone—Betamethasone—Triamcinolone—hematologic cancer	0.00284	0.0123	CrCrCtD
Fluoxymesterone—Dexamethasone—Triamcinolone—hematologic cancer	0.00284	0.0123	CrCrCtD
Fluoxymesterone—Methyltestosterone—Prednisolone—hematologic cancer	0.00282	0.0122	CrCrCtD
Fluoxymesterone—Desoximetasone—Prednisone—hematologic cancer	0.00282	0.0122	CrCrCtD
Fluoxymesterone—Fluorometholone—Prednisone—hematologic cancer	0.00275	0.0119	CrCrCtD
Fluoxymesterone—Triamcinolone—Prednisone—hematologic cancer	0.00275	0.0119	CrCrCtD
Fluoxymesterone—Mometasone—Prednisone—hematologic cancer	0.00275	0.0119	CrCrCtD
Fluoxymesterone—Fluprednidene Acetate—Prednisone—hematologic cancer	0.00275	0.0119	CrCrCtD
Fluoxymesterone—Loteprednol—Prednisone—hematologic cancer	0.00275	0.0119	CrCrCtD
Fluoxymesterone—Desoximetasone—Prednisolone—hematologic cancer	0.00275	0.0119	CrCrCtD
Fluoxymesterone—Prednisolone—Betamethasone—hematologic cancer	0.00272	0.0118	CrCrCtD
Fluoxymesterone—Prednisolone—Dexamethasone—hematologic cancer	0.00272	0.0118	CrCrCtD
Fluoxymesterone—Dexamethasone—Prednisone—hematologic cancer	0.00269	0.0117	CrCrCtD
Fluoxymesterone—Betamethasone—Prednisone—hematologic cancer	0.00269	0.0117	CrCrCtD
Fluoxymesterone—Loteprednol—Prednisolone—hematologic cancer	0.00269	0.0117	CrCrCtD
Fluoxymesterone—Fluprednidene Acetate—Prednisolone—hematologic cancer	0.00269	0.0117	CrCrCtD
Fluoxymesterone—Mometasone—Prednisolone—hematologic cancer	0.00269	0.0117	CrCrCtD
Fluoxymesterone—Triamcinolone—Prednisolone—hematologic cancer	0.00269	0.0117	CrCrCtD
Fluoxymesterone—Fluorometholone—Prednisolone—hematologic cancer	0.00269	0.0117	CrCrCtD
Fluoxymesterone—Prednisolone—Triamcinolone—hematologic cancer	0.00266	0.0115	CrCrCtD
Fluoxymesterone—Betamethasone—Prednisolone—hematologic cancer	0.00263	0.0114	CrCrCtD
Fluoxymesterone—Dexamethasone—Prednisolone—hematologic cancer	0.00263	0.0114	CrCrCtD
Fluoxymesterone—Hydrocortisone—Betamethasone—hematologic cancer	0.00261	0.0113	CrCrCtD
Fluoxymesterone—Hydrocortisone—Dexamethasone—hematologic cancer	0.00261	0.0113	CrCrCtD
Fluoxymesterone—Hydrocortisone—Triamcinolone—hematologic cancer	0.00255	0.0111	CrCrCtD
Fluoxymesterone—Prednisolone—Prednisone—hematologic cancer	0.00252	0.0109	CrCrCtD
Fluoxymesterone—Testosterone—Prednisolone—hematologic cancer	0.00251	0.0109	CrCrCtD
Fluoxymesterone—Hydrocortisone—Prednisone—hematologic cancer	0.00242	0.0105	CrCrCtD
Fluoxymesterone—Hydrocortisone—Prednisolone—hematologic cancer	0.00236	0.0102	CrCrCtD
Fluoxymesterone—PRLR—testis—hematologic cancer	0.00198	0.127	CbGeAlD
Fluoxymesterone—SHBG—hematopoietic system—hematologic cancer	0.000779	0.05	CbGeAlD
Fluoxymesterone—SHBG—gonad—hematologic cancer	0.000593	0.038	CbGeAlD
Fluoxymesterone—AR—hematopoietic system—hematologic cancer	0.000559	0.0359	CbGeAlD
Fluoxymesterone—ESR1—hematopoietic system—hematologic cancer	0.000549	0.0352	CbGeAlD
Fluoxymesterone—SHBG—blood—hematologic cancer	0.000516	0.0331	CbGeAlD
Fluoxymesterone—SHBG—bone marrow—hematologic cancer	0.0005	0.0321	CbGeAlD
Fluoxymesterone—SHBG—testis—hematologic cancer	0.000427	0.0274	CbGeAlD
Fluoxymesterone—AR—gonad—hematologic cancer	0.000425	0.0273	CbGeAlD
Fluoxymesterone—ESR1—gonad—hematologic cancer	0.000417	0.0268	CbGeAlD
Fluoxymesterone—NR3C1—hematopoietic system—hematologic cancer	0.000405	0.026	CbGeAlD
Fluoxymesterone—AR—blood—hematologic cancer	0.000371	0.0238	CbGeAlD
Fluoxymesterone—ESR1—blood—hematologic cancer	0.000364	0.0234	CbGeAlD
Fluoxymesterone—AR—lung—hematologic cancer	0.000325	0.0209	CbGeAlD
Fluoxymesterone—ESR1—lung—hematologic cancer	0.000319	0.0205	CbGeAlD
Fluoxymesterone—NR3C1—gonad—hematologic cancer	0.000308	0.0198	CbGeAlD
Fluoxymesterone—AR—testis—hematologic cancer	0.000307	0.0197	CbGeAlD
Fluoxymesterone—ESR1—testis—hematologic cancer	0.000301	0.0193	CbGeAlD
Fluoxymesterone—NR3C1—blood—hematologic cancer	0.000268	0.0172	CbGeAlD
Fluoxymesterone—NR3C1—bone marrow—hematologic cancer	0.00026	0.0167	CbGeAlD
Fluoxymesterone—NR3C1—lung—hematologic cancer	0.000235	0.0151	CbGeAlD
Fluoxymesterone—AR—lymph node—hematologic cancer	0.000222	0.0143	CbGeAlD
Fluoxymesterone—NR3C1—testis—hematologic cancer	0.000222	0.0143	CbGeAlD
Fluoxymesterone—ESR1—lymph node—hematologic cancer	0.000218	0.014	CbGeAlD
Fluoxymesterone—NR3C1—lymph node—hematologic cancer	0.000161	0.0103	CbGeAlD
Fluoxymesterone—Stanozolol—AR—hematologic cancer	0.00015	0.0804	CrCbGaD
Fluoxymesterone—Oxandrolone—AR—hematologic cancer	0.000135	0.0724	CrCbGaD
Fluoxymesterone—Danazol—CCL2—hematologic cancer	9.73e-05	0.0521	CrCbGaD
Fluoxymesterone—Haemorrhage—Thiotepa—hematologic cancer	8.42e-05	0.00148	CcSEcCtD
Fluoxymesterone—Anxiety—Nilotinib—hematologic cancer	8.36e-05	0.00147	CcSEcCtD
Fluoxymesterone—Anxiety—Imatinib—hematologic cancer	8.31e-05	0.00146	CcSEcCtD
Fluoxymesterone—Nausea—Lomustine—hematologic cancer	8.31e-05	0.00146	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Triamcinolone—hematologic cancer	8.19e-05	0.00144	CcSEcCtD
Fluoxymesterone—Anxiety—Cladribine—hematologic cancer	8.17e-05	0.00144	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Methoxsalen—hematologic cancer	8.13e-05	0.00143	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Imatinib—hematologic cancer	8e-05	0.00141	CcSEcCtD
Fluoxymesterone—Paraesthesia—Procarbazine—hematologic cancer	7.98e-05	0.00141	CcSEcCtD
Fluoxymesterone—Nausea—Mechlorethamine—hematologic cancer	7.96e-05	0.0014	CcSEcCtD
Fluoxymesterone—Alopecia—Bleomycin—hematologic cancer	7.92e-05	0.00139	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Mercaptopurine—hematologic cancer	7.9e-05	0.00139	CcSEcCtD
Fluoxymesterone—Haemoglobin—Carmustine—hematologic cancer	7.86e-05	0.00138	CcSEcCtD
Fluoxymesterone—Haemorrhage—Carmustine—hematologic cancer	7.82e-05	0.00138	CcSEcCtD
Fluoxymesterone—Paraesthesia—Bexarotene—hematologic cancer	7.82e-05	0.00138	CcSEcCtD
Fluoxymesterone—Paraesthesia—Fludarabine—hematologic cancer	7.8e-05	0.00137	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Daunorubicin—hematologic cancer	7.79e-05	0.00137	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Clofarabine—hematologic cancer	7.79e-05	0.00137	CcSEcCtD
Fluoxymesterone—Alopecia—Vinorelbine—hematologic cancer	7.79e-05	0.00137	CcSEcCtD
Fluoxymesterone—Haemoglobin—Alitretinoin—hematologic cancer	7.79e-05	0.00137	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Pentostatin—hematologic cancer	7.76e-05	0.00137	CcSEcCtD
Fluoxymesterone—Haemorrhage—Alitretinoin—hematologic cancer	7.75e-05	0.00137	CcSEcCtD
Fluoxymesterone—Haemoglobin—Ifosfamide—hematologic cancer	7.7e-05	0.00136	CcSEcCtD
Fluoxymesterone—Jaundice cholestatic—Epirubicin—hematologic cancer	7.68e-05	0.00135	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Epirubicin—hematologic cancer	7.68e-05	0.00135	CcSEcCtD
Fluoxymesterone—Testosterone Propionate—UGT1A1—hematologic cancer	7.67e-05	0.0411	CrCbGaD
Fluoxymesterone—Haemorrhage—Ifosfamide—hematologic cancer	7.66e-05	0.00135	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Idarubicin—hematologic cancer	7.48e-05	0.00132	CcSEcCtD
Fluoxymesterone—Alopecia—Thiotepa—hematologic cancer	7.44e-05	0.00131	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Betamethasone—hematologic cancer	7.43e-05	0.00131	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Dexamethasone—hematologic cancer	7.43e-05	0.00131	CcSEcCtD
Fluoxymesterone—Haemoglobin—Mitoxantrone—hematologic cancer	7.31e-05	0.00129	CcSEcCtD
Fluoxymesterone—Haemoglobin—Irinotecan—hematologic cancer	7.31e-05	0.00129	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Teniposide—hematologic cancer	7.28e-05	0.00128	CcSEcCtD
Fluoxymesterone—Haemorrhage—Mitoxantrone—hematologic cancer	7.27e-05	0.00128	CcSEcCtD
Fluoxymesterone—Haemorrhage—Irinotecan—hematologic cancer	7.27e-05	0.00128	CcSEcCtD
Fluoxymesterone—Anxiety—Lenalidomide—hematologic cancer	7.25e-05	0.00128	CcSEcCtD
Fluoxymesterone—Paraesthesia—Nilotinib—hematologic cancer	7.22e-05	0.00127	CcSEcCtD
Fluoxymesterone—Alopecia—Thalidomide—hematologic cancer	7.2e-05	0.00127	CcSEcCtD
Fluoxymesterone—Paraesthesia—Imatinib—hematologic cancer	7.18e-05	0.00127	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Melphalan—hematologic cancer	7.17e-05	0.00126	CcSEcCtD
Fluoxymesterone—Haemoglobin—Gemcitabine—hematologic cancer	7.12e-05	0.00125	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Doxorubicin—hematologic cancer	7.11e-05	0.00125	CcSEcCtD
Fluoxymesterone—Jaundice cholestatic—Doxorubicin—hematologic cancer	7.11e-05	0.00125	CcSEcCtD
Fluoxymesterone—Haemorrhage—Gemcitabine—hematologic cancer	7.08e-05	0.00125	CcSEcCtD
Fluoxymesterone—Headache—Nelarabine—hematologic cancer	7.08e-05	0.00125	CcSEcCtD
Fluoxymesterone—Paraesthesia—Cladribine—hematologic cancer	7.06e-05	0.00124	CcSEcCtD
Fluoxymesterone—Headache—Methoxsalen—hematologic cancer	6.92e-05	0.00122	CcSEcCtD
Fluoxymesterone—Alopecia—Carmustine—hematologic cancer	6.91e-05	0.00122	CcSEcCtD
Fluoxymesterone—Alopecia—Alitretinoin—hematologic cancer	6.85e-05	0.00121	CcSEcCtD
Fluoxymesterone—Paraesthesia—Vinblastine—hematologic cancer	6.77e-05	0.00119	CcSEcCtD
Fluoxymesterone—Alopecia—Ifosfamide—hematologic cancer	6.77e-05	0.00119	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Busulfan—hematologic cancer	6.74e-05	0.00119	CcSEcCtD
Fluoxymesterone—Nausea—Nelarabine—hematologic cancer	6.71e-05	0.00118	CcSEcCtD
Fluoxymesterone—Anxiety—Bortezomib—hematologic cancer	6.67e-05	0.00117	CcSEcCtD
Fluoxymesterone—Headache—Daunorubicin—hematologic cancer	6.63e-05	0.00117	CcSEcCtD
Fluoxymesterone—Headache—Clofarabine—hematologic cancer	6.63e-05	0.00117	CcSEcCtD
Fluoxymesterone—Alopecia—Vincristine—hematologic cancer	6.6e-05	0.00116	CcSEcCtD
Fluoxymesterone—Headache—Anagrelide—hematologic cancer	6.6e-05	0.00116	CcSEcCtD
Fluoxymesterone—Headache—Pentostatin—hematologic cancer	6.6e-05	0.00116	CcSEcCtD
Fluoxymesterone—Nausea—Methoxsalen—hematologic cancer	6.56e-05	0.00116	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Procarbazine—hematologic cancer	6.54e-05	0.00115	CcSEcCtD
Fluoxymesterone—Gynaecomastia—Methotrexate—hematologic cancer	6.45e-05	0.00114	CcSEcCtD
Fluoxymesterone—Paraesthesia—Melphalan—hematologic cancer	6.44e-05	0.00113	CcSEcCtD
Fluoxymesterone—Alopecia—Irinotecan—hematologic cancer	6.43e-05	0.00113	CcSEcCtD
Fluoxymesterone—Alopecia—Mitoxantrone—hematologic cancer	6.43e-05	0.00113	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Bortezomib—hematologic cancer	6.41e-05	0.00113	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Bexarotene—hematologic cancer	6.41e-05	0.00113	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Dasatinib—hematologic cancer	6.41e-05	0.00113	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Fludarabine—hematologic cancer	6.4e-05	0.00113	CcSEcCtD
Fluoxymesterone—Nausea—Mercaptopurine—hematologic cancer	6.37e-05	0.00112	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Bleomycin—hematologic cancer	6.37e-05	0.00112	CcSEcCtD
Fluoxymesterone—Headache—Idarubicin—hematologic cancer	6.36e-05	0.00112	CcSEcCtD
Fluoxymesterone—Desoximetasone—NR3C1—hematologic cancer	6.31e-05	0.0338	CrCbGaD
Fluoxymesterone—Nausea—Clofarabine—hematologic cancer	6.28e-05	0.00111	CcSEcCtD
Fluoxymesterone—Nausea—Daunorubicin—hematologic cancer	6.28e-05	0.00111	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Vinorelbine—hematologic cancer	6.26e-05	0.0011	CcSEcCtD
Fluoxymesterone—Paraesthesia—Lenalidomide—hematologic cancer	6.26e-05	0.0011	CcSEcCtD
Fluoxymesterone—Alopecia—Gemcitabine—hematologic cancer	6.26e-05	0.0011	CcSEcCtD
Fluoxymesterone—Nausea—Anagrelide—hematologic cancer	6.25e-05	0.0011	CcSEcCtD
Fluoxymesterone—Nausea—Pentostatin—hematologic cancer	6.25e-05	0.0011	CcSEcCtD
Fluoxymesterone—Loteprednol—NR3C1—hematologic cancer	6.24e-05	0.0334	CrCbGaD
Fluoxymesterone—Anxiety—Thiotepa—hematologic cancer	6.22e-05	0.0011	CcSEcCtD
Fluoxymesterone—Headache—Teniposide—hematologic cancer	6.19e-05	0.00109	CcSEcCtD
Fluoxymesterone—Fludrocortisone—AR—hematologic cancer	6.15e-05	0.033	CrCbGaD
Fluoxymesterone—Hypersensitivity—Chlorambucil—hematologic cancer	6.06e-05	0.00107	CcSEcCtD
Fluoxymesterone—Nausea—Idarubicin—hematologic cancer	6.03e-05	0.00106	CcSEcCtD
Fluoxymesterone—Anxiety—Thalidomide—hematologic cancer	6.01e-05	0.00106	CcSEcCtD
Fluoxymesterone—Haemoglobin—Prednisolone—hematologic cancer	6e-05	0.00106	CcSEcCtD
Fluoxymesterone—Haemorrhage—Prednisolone—hematologic cancer	5.97e-05	0.00105	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Nilotinib—hematologic cancer	5.93e-05	0.00104	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Imatinib—hematologic cancer	5.89e-05	0.00104	CcSEcCtD
Fluoxymesterone—Nausea—Teniposide—hematologic cancer	5.87e-05	0.00103	CcSEcCtD
Fluoxymesterone—Alopecia—Cisplatin—hematologic cancer	5.83e-05	0.00103	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Cladribine—hematologic cancer	5.79e-05	0.00102	CcSEcCtD
Fluoxymesterone—Anxiety—Carmustine—hematologic cancer	5.78e-05	0.00102	CcSEcCtD
Fluoxymesterone—Paraesthesia—Bortezomib—hematologic cancer	5.76e-05	0.00101	CcSEcCtD
Fluoxymesterone—Headache—Busulfan—hematologic cancer	5.74e-05	0.00101	CcSEcCtD
Fluoxymesterone—Anxiety—Alitretinoin—hematologic cancer	5.72e-05	0.00101	CcSEcCtD
Fluoxymesterone—Paraesthesia—Bleomycin—hematologic cancer	5.72e-05	0.00101	CcSEcCtD
Fluoxymesterone—Paraesthesia—Vinorelbine—hematologic cancer	5.62e-05	0.000991	CcSEcCtD
Fluoxymesterone—Headache—Procarbazine—hematologic cancer	5.56e-05	0.00098	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Vinblastine—hematologic cancer	5.55e-05	0.000978	CcSEcCtD
Fluoxymesterone—Haemoglobin—Triamcinolone—hematologic cancer	5.51e-05	0.000971	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Alitretinoin—hematologic cancer	5.5e-05	0.00097	CcSEcCtD
Fluoxymesterone—Haemorrhage—Triamcinolone—hematologic cancer	5.49e-05	0.000966	CcSEcCtD
Fluoxymesterone—Testosterone Propionate—AR—hematologic cancer	5.48e-05	0.0294	CrCbGaD
Fluoxymesterone—Headache—Bexarotene—hematologic cancer	5.45e-05	0.000961	CcSEcCtD
Fluoxymesterone—Headache—Dasatinib—hematologic cancer	5.45e-05	0.000961	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Ifosfamide—hematologic cancer	5.44e-05	0.000959	CcSEcCtD
Fluoxymesterone—Headache—Fludarabine—hematologic cancer	5.44e-05	0.000958	CcSEcCtD
Fluoxymesterone—Nausea—Busulfan—hematologic cancer	5.44e-05	0.000958	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Methotrexate—hematologic cancer	5.41e-05	0.000953	CcSEcCtD
Fluoxymesterone—Paraesthesia—Thiotepa—hematologic cancer	5.37e-05	0.000946	CcSEcCtD
Fluoxymesterone—Anxiety—Mitoxantrone—hematologic cancer	5.37e-05	0.000946	CcSEcCtD
Fluoxymesterone—Hydrocortamate—NR3C1—hematologic cancer	5.35e-05	0.0287	CrCbGaD
Fluoxymesterone—Alopecia—Etoposide—hematologic cancer	5.34e-05	0.000942	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Vincristine—hematologic cancer	5.3e-05	0.000935	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Melphalan—hematologic cancer	5.28e-05	0.000931	CcSEcCtD
Fluoxymesterone—Nausea—Procarbazine—hematologic cancer	5.28e-05	0.000929	CcSEcCtD
Fluoxymesterone—Cortisone acetate—NR3C1—hematologic cancer	5.26e-05	0.0282	CrCbGaD
Fluoxymesterone—Paraesthesia—Thalidomide—hematologic cancer	5.2e-05	0.000915	CcSEcCtD
Fluoxymesterone—Nausea—Dasatinib—hematologic cancer	5.17e-05	0.000911	CcSEcCtD
Fluoxymesterone—Nausea—Bexarotene—hematologic cancer	5.17e-05	0.000911	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Irinotecan—hematologic cancer	5.17e-05	0.00091	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Mitoxantrone—hematologic cancer	5.17e-05	0.00091	CcSEcCtD
Fluoxymesterone—Nausea—Fludarabine—hematologic cancer	5.16e-05	0.000909	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Lenalidomide—hematologic cancer	5.14e-05	0.000905	CcSEcCtD
Fluoxymesterone—Megestrol acetate—NR3C1—hematologic cancer	5.07e-05	0.0272	CrCbGaD
Fluoxymesterone—Hypersensitivity—Hydroxyurea—hematologic cancer	5.06e-05	0.000892	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Epirubicin—hematologic cancer	5.06e-05	0.000892	CcSEcCtD
Fluoxymesterone—Headache—Nilotinib—hematologic cancer	5.04e-05	0.000888	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Gemcitabine—hematologic cancer	5.03e-05	0.000887	CcSEcCtD
Fluoxymesterone—Headache—Imatinib—hematologic cancer	5.01e-05	0.000883	CcSEcCtD
Fluoxymesterone—Haemoglobin—Betamethasone—hematologic cancer	5e-05	0.000881	CcSEcCtD
Fluoxymesterone—Haemoglobin—Dexamethasone—hematologic cancer	5e-05	0.000881	CcSEcCtD
Fluoxymesterone—Paraesthesia—Carmustine—hematologic cancer	4.99e-05	0.000879	CcSEcCtD
Fluoxymesterone—Haemorrhage—Betamethasone—hematologic cancer	4.98e-05	0.000877	CcSEcCtD
Fluoxymesterone—Haemorrhage—Dexamethasone—hematologic cancer	4.98e-05	0.000877	CcSEcCtD
Fluoxymesterone—Amcinonide—NR3C1—hematologic cancer	4.97e-05	0.0266	CrCbGaD
Fluoxymesterone—Paraesthesia—Alitretinoin—hematologic cancer	4.94e-05	0.000871	CcSEcCtD
Fluoxymesterone—Headache—Cladribine—hematologic cancer	4.92e-05	0.000867	CcSEcCtD
Fluoxymesterone—Nausea—Chlorambucil—hematologic cancer	4.89e-05	0.000861	CcSEcCtD
Fluoxymesterone—Paraesthesia—Ifosfamide—hematologic cancer	4.89e-05	0.000861	CcSEcCtD
Fluoxymesterone—Anxiety—Cisplatin—hematologic cancer	4.88e-05	0.000859	CcSEcCtD
Fluoxymesterone—Danazol—AR—hematologic cancer	4.85e-05	0.026	CrCbGaD
Fluoxymesterone—Nausea—Nilotinib—hematologic cancer	4.78e-05	0.000842	CcSEcCtD
Fluoxymesterone—Paraesthesia—Vincristine—hematologic cancer	4.76e-05	0.000839	CcSEcCtD
Fluoxymesterone—Nausea—Imatinib—hematologic cancer	4.75e-05	0.000837	CcSEcCtD
Fluoxymesterone—Mometasone—NR3C1—hematologic cancer	4.73e-05	0.0253	CrCbGaD
Fluoxymesterone—Hypersensitivity—Bortezomib—hematologic cancer	4.73e-05	0.000833	CcSEcCtD
Fluoxymesterone—Headache—Vinblastine—hematologic cancer	4.72e-05	0.000832	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Cisplatin—hematologic cancer	4.69e-05	0.000826	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Bleomycin—hematologic cancer	4.69e-05	0.000826	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Doxorubicin—hematologic cancer	4.69e-05	0.000825	CcSEcCtD
Fluoxymesterone—Nausea—Cladribine—hematologic cancer	4.67e-05	0.000822	CcSEcCtD
Fluoxymesterone—Spironolactone—AR—hematologic cancer	4.65e-05	0.0249	CrCbGaD
Fluoxymesterone—Paraesthesia—Irinotecan—hematologic cancer	4.64e-05	0.000817	CcSEcCtD
Fluoxymesterone—Paraesthesia—Mitoxantrone—hematologic cancer	4.64e-05	0.000817	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Vinorelbine—hematologic cancer	4.61e-05	0.000813	CcSEcCtD
Fluoxymesterone—Paraesthesia—Gemcitabine—hematologic cancer	4.52e-05	0.000796	CcSEcCtD
Fluoxymesterone—Nausea—Vinblastine—hematologic cancer	4.48e-05	0.000789	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Thiotepa—hematologic cancer	4.41e-05	0.000776	CcSEcCtD
Fluoxymesterone—Alopecia—Dexamethasone—hematologic cancer	4.4e-05	0.000775	CcSEcCtD
Fluoxymesterone—Alopecia—Betamethasone—hematologic cancer	4.4e-05	0.000775	CcSEcCtD
Fluoxymesterone—Headache—Lenalidomide—hematologic cancer	4.37e-05	0.000769	CcSEcCtD
Fluoxymesterone—Medroxyprogesterone Acetate—AR—hematologic cancer	4.36e-05	0.0234	CrCbGaD
Fluoxymesterone—Haemoglobin—Prednisone—hematologic cancer	4.36e-05	0.000768	CcSEcCtD
Fluoxymesterone—Haemorrhage—Prednisone—hematologic cancer	4.33e-05	0.000764	CcSEcCtD
Fluoxymesterone—Headache—Hydroxyurea—hematologic cancer	4.31e-05	0.000759	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Etoposide—hematologic cancer	4.3e-05	0.000757	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Thalidomide—hematologic cancer	4.26e-05	0.000751	CcSEcCtD
Fluoxymesterone—Nausea—Melphalan—hematologic cancer	4.26e-05	0.00075	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Prednisolone—hematologic cancer	4.24e-05	0.000747	CcSEcCtD
Fluoxymesterone—Paraesthesia—Cisplatin—hematologic cancer	4.21e-05	0.000742	CcSEcCtD
Fluoxymesterone—Clobetasol propionate—NR3C1—hematologic cancer	4.17e-05	0.0224	CrCbGaD
Fluoxymesterone—Fludrocortisone—NR3C1—hematologic cancer	4.17e-05	0.0224	CrCbGaD
Fluoxymesterone—Nausea—Lenalidomide—hematologic cancer	4.14e-05	0.00073	CcSEcCtD
Fluoxymesterone—Methyltestosterone—AR—hematologic cancer	4.1e-05	0.022	CrCbGaD
Fluoxymesterone—Hypersensitivity—Carmustine—hematologic cancer	4.09e-05	0.000721	CcSEcCtD
Fluoxymesterone—Nausea—Hydroxyurea—hematologic cancer	4.08e-05	0.000719	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Alitretinoin—hematologic cancer	4.06e-05	0.000715	CcSEcCtD
Fluoxymesterone—Fluorometholone—NR3C1—hematologic cancer	4.02e-05	0.0215	CrCbGaD
Fluoxymesterone—Headache—Bortezomib—hematologic cancer	4.02e-05	0.000708	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Ifosfamide—hematologic cancer	4.01e-05	0.000706	CcSEcCtD
Fluoxymesterone—Headache—Vinorelbine—hematologic cancer	3.92e-05	0.000691	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Vincristine—hematologic cancer	3.91e-05	0.000689	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Triamcinolone—hematologic cancer	3.9e-05	0.000687	CcSEcCtD
Fluoxymesterone—Paraesthesia—Etoposide—hematologic cancer	3.86e-05	0.00068	CcSEcCtD
Fluoxymesterone—Alopecia—Prednisone—hematologic cancer	3.83e-05	0.000675	CcSEcCtD
Fluoxymesterone—Nausea—Bortezomib—hematologic cancer	3.81e-05	0.000671	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Mitoxantrone—hematologic cancer	3.81e-05	0.000671	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Irinotecan—hematologic cancer	3.81e-05	0.000671	CcSEcCtD
Fluoxymesterone—Paraesthesia—Prednisolone—hematologic cancer	3.81e-05	0.00067	CcSEcCtD
Fluoxymesterone—Nausea—Bleomycin—hematologic cancer	3.78e-05	0.000666	CcSEcCtD
Fluoxymesterone—Headache—Thiotepa—hematologic cancer	3.75e-05	0.00066	CcSEcCtD
Fluoxymesterone—Danazol—ESR1—hematologic cancer	3.74e-05	0.02	CrCbGaD
Fluoxymesterone—Nausea—Vinorelbine—hematologic cancer	3.72e-05	0.000655	CcSEcCtD
Fluoxymesterone—Anxiety—Betamethasone—hematologic cancer	3.68e-05	0.000648	CcSEcCtD
Fluoxymesterone—Anxiety—Dexamethasone—hematologic cancer	3.68e-05	0.000648	CcSEcCtD
Fluoxymesterone—Haemoglobin—Methotrexate—hematologic cancer	3.64e-05	0.000641	CcSEcCtD
Fluoxymesterone—Headache—Thalidomide—hematologic cancer	3.62e-05	0.000639	CcSEcCtD
Fluoxymesterone—Haemorrhage—Methotrexate—hematologic cancer	3.62e-05	0.000638	CcSEcCtD
Fluoxymesterone—Nausea—Thiotepa—hematologic cancer	3.55e-05	0.000626	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Betamethasone—hematologic cancer	3.54e-05	0.000623	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Dexamethasone—hematologic cancer	3.54e-05	0.000623	CcSEcCtD
Fluoxymesterone—Paraesthesia—Triamcinolone—hematologic cancer	3.5e-05	0.000617	CcSEcCtD
Fluoxymesterone—Headache—Carmustine—hematologic cancer	3.48e-05	0.000613	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Cisplatin—hematologic cancer	3.46e-05	0.000609	CcSEcCtD
Fluoxymesterone—Headache—Alitretinoin—hematologic cancer	3.45e-05	0.000608	CcSEcCtD
Fluoxymesterone—Nausea—Thalidomide—hematologic cancer	3.44e-05	0.000605	CcSEcCtD
Fluoxymesterone—Haemoglobin—Epirubicin—hematologic cancer	3.41e-05	0.0006	CcSEcCtD
Fluoxymesterone—Haemorrhage—Epirubicin—hematologic cancer	3.39e-05	0.000597	CcSEcCtD
Fluoxymesterone—Medroxyprogesterone Acetate—ESR1—hematologic cancer	3.36e-05	0.018	CrCbGaD
Fluoxymesterone—Headache—Vincristine—hematologic cancer	3.32e-05	0.000585	CcSEcCtD
Fluoxymesterone—Nausea—Carmustine—hematologic cancer	3.3e-05	0.000581	CcSEcCtD
Fluoxymesterone—Triamcinolone—NR3C1—hematologic cancer	3.28e-05	0.0176	CrCbGaD
Fluoxymesterone—Nausea—Alitretinoin—hematologic cancer	3.27e-05	0.000576	CcSEcCtD
Fluoxymesterone—Headache—Irinotecan—hematologic cancer	3.24e-05	0.00057	CcSEcCtD
Fluoxymesterone—Headache—Mitoxantrone—hematologic cancer	3.24e-05	0.00057	CcSEcCtD
Fluoxymesterone—Nausea—Ifosfamide—hematologic cancer	3.23e-05	0.000569	CcSEcCtD
Fluoxymesterone—Anxiety—Prednisone—hematologic cancer	3.2e-05	0.000564	CcSEcCtD
Fluoxymesterone—Alopecia—Methotrexate—hematologic cancer	3.2e-05	0.000564	CcSEcCtD
Fluoxymesterone—Paraesthesia—Dexamethasone—hematologic cancer	3.18e-05	0.000559	CcSEcCtD
Fluoxymesterone—Paraesthesia—Betamethasone—hematologic cancer	3.18e-05	0.000559	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Etoposide—hematologic cancer	3.17e-05	0.000558	CcSEcCtD
Fluoxymesterone—Spironolactone—NR3C1—hematologic cancer	3.15e-05	0.0169	CrCbGaD
Fluoxymesterone—Haemoglobin—Doxorubicin—hematologic cancer	3.15e-05	0.000555	CcSEcCtD
Fluoxymesterone—Headache—Gemcitabine—hematologic cancer	3.15e-05	0.000555	CcSEcCtD
Fluoxymesterone—Nausea—Vincristine—hematologic cancer	3.15e-05	0.000555	CcSEcCtD
Fluoxymesterone—Haemorrhage—Doxorubicin—hematologic cancer	3.14e-05	0.000553	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Prednisolone—hematologic cancer	3.12e-05	0.00055	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Prednisone—hematologic cancer	3.08e-05	0.000543	CcSEcCtD
Fluoxymesterone—Nausea—Mitoxantrone—hematologic cancer	3.07e-05	0.000541	CcSEcCtD
Fluoxymesterone—Nausea—Irinotecan—hematologic cancer	3.07e-05	0.000541	CcSEcCtD
Fluoxymesterone—Alopecia—Epirubicin—hematologic cancer	3e-05	0.000528	CcSEcCtD
Fluoxymesterone—Nausea—Gemcitabine—hematologic cancer	2.99e-05	0.000527	CcSEcCtD
Fluoxymesterone—Medroxyprogesterone Acetate—NR3C1—hematologic cancer	2.96e-05	0.0158	CrCbGaD
Fluoxymesterone—Hypersensitivity—Triamcinolone—hematologic cancer	2.87e-05	0.000506	CcSEcCtD
Fluoxymesterone—Progesterone—SLC22A1—hematologic cancer	2.83e-05	0.0152	CrCbGaD
Fluoxymesterone—Nausea—Cisplatin—hematologic cancer	2.79e-05	0.000491	CcSEcCtD
Fluoxymesterone—Alopecia—Doxorubicin—hematologic cancer	2.77e-05	0.000488	CcSEcCtD
Fluoxymesterone—Paraesthesia—Prednisone—hematologic cancer	2.77e-05	0.000487	CcSEcCtD
Fluoxymesterone—Prednisolone—NR3C1—hematologic cancer	2.74e-05	0.0147	CrCbGaD
Fluoxymesterone—Headache—Etoposide—hematologic cancer	2.69e-05	0.000474	CcSEcCtD
Fluoxymesterone—Betamethasone—NR3C1—hematologic cancer	2.68e-05	0.0144	CrCbGaD
Fluoxymesterone—Testosterone—SLC22A1—hematologic cancer	2.68e-05	0.0144	CrCbGaD
Fluoxymesterone—Headache—Prednisolone—hematologic cancer	2.66e-05	0.000468	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Methotrexate—hematologic cancer	2.57e-05	0.000453	CcSEcCtD
Fluoxymesterone—Nausea—Etoposide—hematologic cancer	2.55e-05	0.00045	CcSEcCtD
Fluoxymesterone—Nausea—Prednisolone—hematologic cancer	2.52e-05	0.000444	CcSEcCtD
Fluoxymesterone—Progesterone—AR—hematologic cancer	2.52e-05	0.0135	CrCbGaD
Fluoxymesterone—Anxiety—Epirubicin—hematologic cancer	2.5e-05	0.000441	CcSEcCtD
Fluoxymesterone—Megestrol acetate—ABCB1—hematologic cancer	2.45e-05	0.0131	CrCbGaD
Fluoxymesterone—Headache—Triamcinolone—hematologic cancer	2.44e-05	0.00043	CcSEcCtD
Fluoxymesterone—Hydrocortisone—ABCG2—hematologic cancer	2.43e-05	0.013	CrCbGaD
Fluoxymesterone—Anaphylactic shock—Epirubicin—hematologic cancer	2.41e-05	0.000424	CcSEcCtD
Fluoxymesterone—Testosterone—AR—hematologic cancer	2.38e-05	0.0128	CrCbGaD
Fluoxymesterone—Anxiety—Doxorubicin—hematologic cancer	2.32e-05	0.000408	CcSEcCtD
Fluoxymesterone—Nausea—Triamcinolone—hematologic cancer	2.32e-05	0.000408	CcSEcCtD
Fluoxymesterone—Paraesthesia—Methotrexate—hematologic cancer	2.31e-05	0.000407	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Prednisone—hematologic cancer	2.27e-05	0.0004	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Doxorubicin—hematologic cancer	2.23e-05	0.000393	CcSEcCtD
Fluoxymesterone—Headache—Betamethasone—hematologic cancer	2.22e-05	0.00039	CcSEcCtD
Fluoxymesterone—Headache—Dexamethasone—hematologic cancer	2.22e-05	0.00039	CcSEcCtD
Fluoxymesterone—Paraesthesia—Epirubicin—hematologic cancer	2.16e-05	0.000381	CcSEcCtD
Fluoxymesterone—Nausea—Betamethasone—hematologic cancer	2.1e-05	0.00037	CcSEcCtD
Fluoxymesterone—Nausea—Dexamethasone—hematologic cancer	2.1e-05	0.00037	CcSEcCtD
Fluoxymesterone—Hydrocortisone—NR3C1—hematologic cancer	2.1e-05	0.0112	CrCbGaD
Fluoxymesterone—Paraesthesia—Doxorubicin—hematologic cancer	2e-05	0.000353	CcSEcCtD
Fluoxymesterone—Progesterone—ESR1—hematologic cancer	1.94e-05	0.0104	CrCbGaD
Fluoxymesterone—Headache—Prednisone—hematologic cancer	1.93e-05	0.00034	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Methotrexate—hematologic cancer	1.9e-05	0.000334	CcSEcCtD
Fluoxymesterone—Testosterone—ABCG2—hematologic cancer	1.87e-05	0.01	CrCbGaD
Fluoxymesterone—Nausea—Prednisone—hematologic cancer	1.83e-05	0.000322	CcSEcCtD
Fluoxymesterone—Dexamethasone—ABCG2—hematologic cancer	1.81e-05	0.0097	CrCbGaD
Fluoxymesterone—Hypersensitivity—Epirubicin—hematologic cancer	1.77e-05	0.000313	CcSEcCtD
Fluoxymesterone—Progesterone—NR3C1—hematologic cancer	1.71e-05	0.00915	CrCbGaD
Fluoxymesterone—Hypersensitivity—Doxorubicin—hematologic cancer	1.64e-05	0.000289	CcSEcCtD
Fluoxymesterone—Headache—Methotrexate—hematologic cancer	1.61e-05	0.000284	CcSEcCtD
Fluoxymesterone—Dexamethasone—NR3C1—hematologic cancer	1.56e-05	0.00837	CrCbGaD
Fluoxymesterone—Nausea—Methotrexate—hematologic cancer	1.53e-05	0.000269	CcSEcCtD
Fluoxymesterone—Spironolactone—ABCB1—hematologic cancer	1.52e-05	0.00816	CrCbGaD
Fluoxymesterone—Headache—Epirubicin—hematologic cancer	1.51e-05	0.000266	CcSEcCtD
Fluoxymesterone—Norethindrone—ALB—hematologic cancer	1.48e-05	0.00794	CrCbGaD
Fluoxymesterone—Nausea—Epirubicin—hematologic cancer	1.43e-05	0.000252	CcSEcCtD
Fluoxymesterone—Norethindrone—ABCB1—hematologic cancer	1.41e-05	0.00758	CrCbGaD
Fluoxymesterone—Methyltestosterone—ALB—hematologic cancer	1.41e-05	0.00754	CrCbGaD
Fluoxymesterone—Headache—Doxorubicin—hematologic cancer	1.4e-05	0.000246	CcSEcCtD
Fluoxymesterone—Nausea—Doxorubicin—hematologic cancer	1.32e-05	0.000233	CcSEcCtD
Fluoxymesterone—Prednisolone—ABCB1—hematologic cancer	1.32e-05	0.00709	CrCbGaD
Fluoxymesterone—Betamethasone—ABCB1—hematologic cancer	1.3e-05	0.00694	CrCbGaD
Fluoxymesterone—Hydrocortisone—ABCB1—hematologic cancer	1.01e-05	0.00542	CrCbGaD
Fluoxymesterone—Progesterone—ABCB1—hematologic cancer	8.24e-06	0.00441	CrCbGaD
Fluoxymesterone—Testosterone—ALB—hematologic cancer	8.16e-06	0.00437	CrCbGaD
Fluoxymesterone—Testosterone—ABCB1—hematologic cancer	7.79e-06	0.00417	CrCbGaD
Fluoxymesterone—Dexamethasone—ABCB1—hematologic cancer	7.53e-06	0.00404	CrCbGaD
Fluoxymesterone—PRLR—Signaling Pathways—MDM2—hematologic cancer	5.86e-06	0.000103	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—KRAS—hematologic cancer	5.85e-06	0.000103	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—HSPB1—hematologic cancer	5.83e-06	0.000102	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—EIF4EBP1—hematologic cancer	5.83e-06	0.000102	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	5.82e-06	0.000102	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—AGO2—hematologic cancer	5.74e-06	0.000101	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PIK3CB—hematologic cancer	5.7e-06	0.0001	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MTOR—hematologic cancer	5.7e-06	0.0001	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	5.68e-06	9.96e-05	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—IL6—hematologic cancer	5.67e-06	9.96e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—AGO2—hematologic cancer	5.65e-06	9.91e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—H3F3B—hematologic cancer	5.62e-06	9.86e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—DNMT3B—hematologic cancer	5.62e-06	9.86e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—SMC1A—hematologic cancer	5.58e-06	9.8e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—NR3C1—hematologic cancer	5.56e-06	9.76e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—DNMT3B—hematologic cancer	5.53e-06	9.71e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—H3F3B—hematologic cancer	5.53e-06	9.71e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	5.52e-06	9.68e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—KRAS—hematologic cancer	5.51e-06	9.68e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—KRAS—hematologic cancer	5.49e-06	9.62e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—H3F3A—hematologic cancer	5.47e-06	9.6e-05	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	5.45e-06	9.56e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ARHGEF12—hematologic cancer	5.41e-06	9.49e-05	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—PIK3CA—hematologic cancer	5.38e-06	9.43e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	5.38e-06	9.43e-05	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—CREBBP—hematologic cancer	5.37e-06	9.43e-05	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—AKT1—hematologic cancer	5.37e-06	9.43e-05	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CDKN1B—hematologic cancer	5.35e-06	9.39e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—TNF—hematologic cancer	5.33e-06	9.36e-05	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	5.27e-06	9.25e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ARHGEF1—hematologic cancer	5.27e-06	9.25e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—EZH2—hematologic cancer	5.25e-06	9.21e-05	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CASP3—hematologic cancer	5.25e-06	9.2e-05	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IL2—hematologic cancer	5.24e-06	9.19e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—RPS14—hematologic cancer	5.14e-06	9.02e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—PARP1—hematologic cancer	5.14e-06	9.02e-05	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CCND1—hematologic cancer	5.11e-06	8.96e-05	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—JUN—hematologic cancer	5.1e-06	8.94e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	5.08e-06	8.92e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—RPS14—hematologic cancer	5.06e-06	8.88e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NUP98—hematologic cancer	5.06e-06	8.88e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—PIK3CA—hematologic cancer	5.04e-06	8.84e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—NUP98—hematologic cancer	4.98e-06	8.74e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—IL6—hematologic cancer	4.98e-06	8.74e-05	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—HRAS—hematologic cancer	4.98e-06	8.73e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—HDAC2—hematologic cancer	4.96e-06	8.7e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	4.95e-06	8.68e-05	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CDKN1A—hematologic cancer	4.94e-06	8.67e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	4.93e-06	8.66e-05	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PTEN—hematologic cancer	4.93e-06	8.65e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—TP53—hematologic cancer	4.9e-06	8.6e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NUP214—hematologic cancer	4.88e-06	8.56e-05	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MAPK8—hematologic cancer	4.82e-06	8.46e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—NUP214—hematologic cancer	4.8e-06	8.43e-05	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IL6—hematologic cancer	4.76e-06	8.35e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCL17—hematologic cancer	4.73e-06	8.29e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AGRN—hematologic cancer	4.73e-06	8.29e-05	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—EP300—hematologic cancer	4.7e-06	8.25e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—HRAS—hematologic cancer	4.66e-06	8.18e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—ESR1—hematologic cancer	4.65e-06	8.16e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CXCR5—hematologic cancer	4.64e-06	8.14e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	4.61e-06	8.08e-05	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—SRC—hematologic cancer	4.57e-06	8.02e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	4.57e-06	8.02e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—NOTCH1—hematologic cancer	4.57e-06	8.01e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—LEF1—hematologic cancer	4.56e-06	8e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—NOTCH1—hematologic cancer	4.5e-06	7.89e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—EIF4EBP1—hematologic cancer	4.49e-06	7.88e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—HSPB1—hematologic cancer	4.49e-06	7.88e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GNA13—hematologic cancer	4.48e-06	7.86e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—IL6—hematologic cancer	4.46e-06	7.83e-05	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	4.45e-06	7.81e-05	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—VEGFA—hematologic cancer	4.45e-06	7.81e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—EIF4EBP1—hematologic cancer	4.42e-06	7.76e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—HSPB1—hematologic cancer	4.42e-06	7.76e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TIAM1—hematologic cancer	4.41e-06	7.74e-05	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—STAT3—hematologic cancer	4.41e-06	7.73e-05	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NRAS—hematologic cancer	4.4e-06	7.71e-05	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—AKT1—hematologic cancer	4.39e-06	7.71e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—IL6—hematologic cancer	4.3e-06	7.55e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—SMC1A—hematologic cancer	4.3e-06	7.55e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—JAK3—hematologic cancer	4.28e-06	7.5e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—SMC1A—hematologic cancer	4.24e-06	7.43e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—H3F3A—hematologic cancer	4.22e-06	7.4e-05	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MAPK3—hematologic cancer	4.21e-06	7.39e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	4.2e-06	7.37e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—H3F3A—hematologic cancer	4.15e-06	7.29e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—CREBBP—hematologic cancer	4.14e-06	7.26e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—AKT1—hematologic cancer	4.14e-06	7.26e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—AKT1—hematologic cancer	4.12e-06	7.22e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CXCL13—hematologic cancer	4.1e-06	7.19e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCR7—hematologic cancer	4.1e-06	7.19e-05	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MYC—hematologic cancer	4.1e-06	7.19e-05	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TGFB1—hematologic cancer	4.09e-06	7.17e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—CREBBP—hematologic cancer	4.08e-06	7.15e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	4.06e-06	7.13e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NCOR2—hematologic cancer	4.05e-06	7.1e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—EZH2—hematologic cancer	4.04e-06	7.1e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IL3RA—hematologic cancer	3.99e-06	7.01e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CRKL—hematologic cancer	3.99e-06	7.01e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—EZH2—hematologic cancer	3.98e-06	6.99e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—CDKN2B—hematologic cancer	3.96e-06	6.95e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—PARP1—hematologic cancer	3.96e-06	6.95e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—PARP1—hematologic cancer	3.9e-06	6.84e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—RGS2—hematologic cancer	3.85e-06	6.76e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—HDAC2—hematologic cancer	3.82e-06	6.7e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TRIO—hematologic cancer	3.81e-06	6.69e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TRH—hematologic cancer	3.81e-06	6.69e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CMA1—hematologic cancer	3.81e-06	6.69e-05	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—KRAS—hematologic cancer	3.78e-06	6.64e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—HDAC2—hematologic cancer	3.76e-06	6.6e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—NCOR1—hematologic cancer	3.76e-06	6.59e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AGO2—hematologic cancer	3.73e-06	6.54e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SPHK1—hematologic cancer	3.73e-06	6.54e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—LPAR1—hematologic cancer	3.69e-06	6.48e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HDAC9—hematologic cancer	3.69e-06	6.48e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—H3F3B—hematologic cancer	3.65e-06	6.41e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—NR3C1—hematologic cancer	3.48e-06	6.1e-05	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PIK3CA—hematologic cancer	3.48e-06	6.1e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	3.43e-06	6.02e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CNR2—hematologic cancer	3.4e-06	5.96e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PDE4B—hematologic cancer	3.4e-06	5.96e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FGF19—hematologic cancer	3.37e-06	5.91e-05	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TP53—hematologic cancer	3.36e-06	5.9e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—RAC2—hematologic cancer	3.34e-06	5.86e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—DKK1—hematologic cancer	3.32e-06	5.82e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—AR—hematologic cancer	3.31e-06	5.81e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—STAT5B—hematologic cancer	3.29e-06	5.77e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—AR—hematologic cancer	3.26e-06	5.72e-05	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—HRAS—hematologic cancer	3.22e-06	5.64e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ADCY7—hematologic cancer	3.19e-06	5.6e-05	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—MYC—hematologic cancer	3.19e-06	5.6e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—XIAP—hematologic cancer	3.11e-06	5.45e-05	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IL6—hematologic cancer	3.08e-06	5.4e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—CDKN2B—hematologic cancer	3.05e-06	5.35e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SH2B3—hematologic cancer	3.03e-06	5.31e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SMARCA4—hematologic cancer	3.03e-06	5.31e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—MAPK14—hematologic cancer	3.01e-06	5.28e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GZMB—hematologic cancer	3.01e-06	5.28e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—CDKN2B—hematologic cancer	3.01e-06	5.27e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—ESR1—hematologic cancer	2.95e-06	5.18e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CTNNA1—hematologic cancer	2.94e-06	5.15e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HSPB1—hematologic cancer	2.92e-06	5.12e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—EIF4EBP1—hematologic cancer	2.92e-06	5.12e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCL3—hematologic cancer	2.92e-06	5.12e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NCOR1—hematologic cancer	2.89e-06	5.08e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PTHLH—hematologic cancer	2.89e-06	5.07e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SDC1—hematologic cancer	2.89e-06	5.07e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—NOTCH1—hematologic cancer	2.85e-06	5.01e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—NCOR1—hematologic cancer	2.85e-06	5e-05	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—AKT1—hematologic cancer	2.84e-06	4.98e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PTGER4—hematologic cancer	2.81e-06	4.93e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—LCK—hematologic cancer	2.8e-06	4.91e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—H3F3A—hematologic cancer	2.74e-06	4.81e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NR3C1—hematologic cancer	2.68e-06	4.7e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PRKCZ—hematologic cancer	2.67e-06	4.68e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—CREBBP—hematologic cancer	2.59e-06	4.54e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PARP1—hematologic cancer	2.57e-06	4.52e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FBXW7—hematologic cancer	2.53e-06	4.44e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HDAC2—hematologic cancer	2.48e-06	4.36e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CXCR4—hematologic cancer	2.48e-06	4.36e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—MYC—hematologic cancer	2.46e-06	4.31e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CBL—hematologic cancer	2.42e-06	4.25e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—MYC—hematologic cancer	2.42e-06	4.24e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IL3—hematologic cancer	2.39e-06	4.2e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PTPN1—hematologic cancer	2.35e-06	4.13e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—MAPK14—hematologic cancer	2.32e-06	4.07e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—RASGRP1—hematologic cancer	2.32e-06	4.06e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HSP90AA1—hematologic cancer	2.31e-06	4.05e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SYK—hematologic cancer	2.31e-06	4.05e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—MAPK14—hematologic cancer	2.28e-06	4.01e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—ESR1—hematologic cancer	2.24e-06	3.93e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—STAT1—hematologic cancer	2.23e-06	3.91e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NOTCH1—hematologic cancer	2.2e-06	3.86e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—NOTCH1—hematologic cancer	2.16e-06	3.8e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GRB2—hematologic cancer	2.08e-06	3.65e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PDGFA—hematologic cancer	2.08e-06	3.65e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—KITLG—hematologic cancer	2.05e-06	3.59e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—STAT5A—hematologic cancer	2e-06	3.51e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—CREBBP—hematologic cancer	1.99e-06	3.5e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CDKN2B—hematologic cancer	1.98e-06	3.48e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—CREBBP—hematologic cancer	1.96e-06	3.44e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CD86—hematologic cancer	1.92e-06	3.37e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HES1—hematologic cancer	1.89e-06	3.32e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NCOR1—hematologic cancer	1.88e-06	3.3e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CSF2—hematologic cancer	1.86e-06	3.27e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FGF1—hematologic cancer	1.86e-06	3.27e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FOXO1—hematologic cancer	1.83e-06	3.22e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PDGFRB—hematologic cancer	1.83e-06	3.21e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PDGFRA—hematologic cancer	1.8e-06	3.16e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PRKCG—hematologic cancer	1.8e-06	3.15e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—JAK1—hematologic cancer	1.8e-06	3.15e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IL2RA—hematologic cancer	1.68e-06	2.94e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TERT—hematologic cancer	1.66e-06	2.91e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PDGFB—hematologic cancer	1.62e-06	2.84e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TSC2—hematologic cancer	1.58e-06	2.78e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—MAPK3—hematologic cancer	1.58e-06	2.77e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—MYC—hematologic cancer	1.54e-06	2.69e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FGFR3—hematologic cancer	1.52e-06	2.67e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MAPK14—hematologic cancer	1.51e-06	2.64e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FN1—hematologic cancer	1.46e-06	2.56e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—BAD—hematologic cancer	1.44e-06	2.53e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NFKBIA—hematologic cancer	1.44e-06	2.53e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NOTCH1—hematologic cancer	1.43e-06	2.51e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CD80—hematologic cancer	1.4e-06	2.46e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—KIT—hematologic cancer	1.4e-06	2.45e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PIK3CG—hematologic cancer	1.4e-06	2.45e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PTPN11—hematologic cancer	1.37e-06	2.41e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CREB1—hematologic cancer	1.33e-06	2.33e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—BRAF—hematologic cancer	1.31e-06	2.3e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCL2—hematologic cancer	1.3e-06	2.28e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IL6R—hematologic cancer	1.3e-06	2.28e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CREBBP—hematologic cancer	1.3e-06	2.27e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MAP2K1—hematologic cancer	1.24e-06	2.17e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PIK3CD—hematologic cancer	1.23e-06	2.16e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—MAPK3—hematologic cancer	1.22e-06	2.13e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—MAPK3—hematologic cancer	1.2e-06	2.1e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—MYC—hematologic cancer	1.18e-06	2.08e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FGF2—hematologic cancer	1.18e-06	2.06e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—MYC—hematologic cancer	1.16e-06	2.04e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PIK3R1—hematologic cancer	1.16e-06	2.04e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—JAK2—hematologic cancer	1.13e-06	1.98e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MDM2—hematologic cancer	1.1e-06	1.93e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MTOR—hematologic cancer	1.07e-06	1.88e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PIK3CB—hematologic cancer	1.07e-06	1.88e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—AKT1—hematologic cancer	1.06e-06	1.87e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CDKN1B—hematologic cancer	1.01e-06	1.76e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CASP3—hematologic cancer	9.85e-07	1.73e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IL2—hematologic cancer	9.84e-07	1.73e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCND1—hematologic cancer	9.59e-07	1.68e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—JUN—hematologic cancer	9.57e-07	1.68e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CDKN1A—hematologic cancer	9.28e-07	1.63e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PTEN—hematologic cancer	9.25e-07	1.62e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MAPK8—hematologic cancer	9.05e-07	1.59e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—EP300—hematologic cancer	8.83e-07	1.55e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SRC—hematologic cancer	8.58e-07	1.51e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—VEGFA—hematologic cancer	8.36e-07	1.47e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—STAT3—hematologic cancer	8.28e-07	1.45e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NRAS—hematologic cancer	8.26e-07	1.45e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—AKT1—hematologic cancer	8.2e-07	1.44e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—AKT1—hematologic cancer	8.08e-07	1.42e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MAPK3—hematologic cancer	7.91e-07	1.39e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MYC—hematologic cancer	7.69e-07	1.35e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TGFB1—hematologic cancer	7.67e-07	1.35e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—KRAS—hematologic cancer	7.11e-07	1.25e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PIK3CA—hematologic cancer	6.53e-07	1.15e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TP53—hematologic cancer	6.32e-07	1.11e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HRAS—hematologic cancer	6.04e-07	1.06e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IL6—hematologic cancer	5.78e-07	1.01e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AKT1—hematologic cancer	5.33e-07	9.36e-06	CbGpPWpGaD
